1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. AstraZeneca Pharma India Limited
  6. News
  7. Summary
    506820   INE203A01020

ASTRAZENECA PHARMA INDIA LIMITED

(506820)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancials 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

AstraZeneca Pharma India's Net Profit Slumps in Fiscal Q2

11/09/2021 | 10:37pm EDT


© MT Newswires 2021
Stocks mentioned in the article
ChangeLast1st jan.
ASTRAZENECA PHARMA INDIA LIMITED -2.57% 2580.05 End-of-day quote.-16.78%
ASTRAZENECA PLC -0.38% 10560 Delayed Quote.22.12%
All news about ASTRAZENECA PHARMA INDIA LIMITED
03/21India considers opening COVID boosters to all adults, sources say
RE
02/23ASTRAZENECA PHARMA INDIA : Postal Ballot
PU
02/08AstraZeneca Pharma India Limited Reports Earnings Results for the Third Quarter and Nin..
CI
02/03Regio Biosciences Enters into License Agreement with Astrazeneca for Phase 2A Asset in ..
CI
02/02Astrazeneca Pharma India Limited Announces Resignation of Kimsuka Narsimhan as Independ..
CI
2021AstraZeneca Pharma India Limited Appoints Shilpa Shridhar Divekar as Additional Directo..
CI
2021AstraZeneca Pharma India's Net Profit Slumps in Fiscal Q2
MT
2021ASTRAZENECA PHARMA INDIA : Gets Import Nod for Selumetinib
MT
2021ASTRAZENECA PHARMA INDIA LIMITED : Ex-dividend day for interim dividend
FA
2021AstraZeneca Pharma India Limited Approves the Payment of Interim Dividend for the Finan..
CI
More news
Financials
Sales 2021 8 136 M 105 M 105 M
Net income 2021 933 M 12,0 M 12,0 M
Net cash 2021 3 402 M 43,9 M 43,9 M
P/E ratio 2021 80,7x
Yield 2021 0,07%
Capitalization 64 501 M 832 M 832 M
EV / Sales 2020 6,90x
EV / Sales 2021 8,83x
Nbr of Employees -
Free-Float 15,3%
Chart ASTRAZENECA PHARMA INDIA LIMITED
Duration : Period :
AstraZeneca Pharma India Limited Technical Analysis Chart | 506820 | INE203A01020 | MarketScreener
Technical analysis trends ASTRAZENECA PHARMA INDIA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Managers and Directors
Gagandeep Singh Bedi Managing Director & Executive Director
Rajesh Marwaha Chief Financial Officer & Executive Director
Narayan Keelveedhi Seshadri Non-Executive Chairman
Pratap Rudra Secretary, Compliance Officer & Legal Counsel
Revathy Ashok Independent Non-Executive Director
Sector and Competitors
1st jan.Capi. (M$)
ASTRAZENECA PHARMA INDIA LIMITED-16.78%832
JOHNSON & JOHNSON6.04%477 336
PFIZER, INC.-9.55%299 678
ROCHE HOLDING AG-12.57%281 309
ELI LILLY AND COMPANY10.77%275 413
ABBVIE INC.10.13%263 494